Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer

被引:37
|
作者
Li, Jun [1 ]
Wang, Zhenhua [1 ]
Mao, Kai [1 ]
Guo, Xixi [1 ]
机构
[1] Xinxiang Cent Hosp, Dept Thorac Surg Oncol, Xinxiang 453000, Henan, Peoples R China
关键词
non-small cell lung cancer; postoperative survival time; relapse; T helper 1/T helper 2 cytokine shift; TH2; CYTOKINES; IMMUNOTHERAPY; CHEMOTHERAPY; THERAPY; MARKERS; BALANCE;
D O I
10.3892/ol.2014.2391
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to explore the T helper 1 (Th1)/Th2 cytokine shift and its clinical significance in the peripheral blood and tumor tissues of non-small cell lung cancer (NSCLC) patients. In total, 124 NSCLC patients who were admitted to Xinxiang Central Hospital were selected, along with 124 healthy individuals undergoing physical examination at the same hospital during this period (as controls). ELISA was conducted to detect the Th1 and Th2 cytokine levels in the peripheral blood of patients in the two groups prior to and following radical surgery treatment. In addition, the Th1 and Th2 cytokine levels in the peripheral blood of the observation group were measured following surgery to analyze the correlation between relapse and survival. Compared with the control group, interleukin 4 (IL-4) and IL-10 concentrations in the peripheral blood of the observation group, prior to and following surgery, were significantly higher, whilst IL-2 and interferon-gamma (INF-gamma) concentrations were significantly lower (P<0.05). In the observation group, the IL-4 and IL-10 concentrations were significantly decreased following surgery, as compared with prior to surgery (P<0.05), whilst the IL-2 and INF-gamma concentrations increased significantly (P<0.05). The one- and three-year cumulative relapse frequencies of patients with postoperative IL-4 abnormalities were significantly increased compared with those in patients with normal IL-4 levels following surgery (P<0.05), and the median survival time and survival rate significantly decreased in patients with postoperative IL-4 abnormalities (P<0.05). In terms of the three-year cumulative relapse rate, median survival time, and one- and three-year cumulative survival rate, patients with postoperative IL-2, IL-10 and INF-gamma level abnormalities did not present any statistical significance compared with those without such abnormalities (P>0.05). In conclusion, Th2 cytokines dominate the peripheral blood of NSCLC patients and radical surgery treatment may improve the Th1/Th2 shift in patients. Furthermore, postoperative IL-4 levels were observed to correlate with relapse and the survival rate of patients; therefore, IL-4 may be considered as an auxiliary in the postoperative diagnosis during clinical practice.
引用
收藏
页码:1682 / 1686
页数:5
相关论文
共 50 条
  • [1] Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer
    Ito, N
    Suzuki, Y
    Taniguchi, Y
    Ishiguro, K
    Nakamura, H
    Ohgi, S
    ANTICANCER RESEARCH, 2005, 25 (3B) : 2027 - 2031
  • [2] The Role of Circulating T Follicular Helper Cells and Regulatory Cells in Non-Small Cell Lung Cancer Patients
    Guo, Z.
    Liang, H.
    Xu, Y.
    Liu, L.
    Ren, X.
    Zhang, S.
    Wei, S.
    Xu, P.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (02) : 107 - 112
  • [3] Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma
    Sharma, Alpana
    Khan, Rehan
    Joshi, Suhasini
    Kumar, Lalit
    Sharma, Manoj
    LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 920 - 927
  • [4] Function of follicular helper T cell is impaired and correlates with survival time in non-small cell lung cancer
    Ma, Qin-Yun
    Huang, Da-Yu
    Zhang, Hui-Jun
    Chen, Ji
    Miller, Wendy
    Chen, Xiao-Feng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 41 : 1 - 7
  • [5] In Response to 'The role of circulating T follicular helper cells and regulatory cells in non-small cell lung cancer patients'
    Vyas, A. K.
    Khosla, R.
    Trehanpati, N.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 248 - 248
  • [6] Helper T cell changes in peripheral blood of metastatic non-small cell lung cancer patients receiving cryotherapy and immunotherapy
    Vasiliauskas, Gediminas
    Sabeckyte, Evelina
    Skrodeniene, Erika
    Poskiene, Lina
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] T-Helper1/T-Helper2 Cytokine Imbalance in the Iris of Patients with Glaucoma
    Wong, ManSin
    Huang, Ping
    Li, Weiyi
    Li, Ying
    Zhang, Samuel S.
    Zhang, Chun
    PLOS ONE, 2015, 10 (03):
  • [8] T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression?
    Jain, Sarika
    Kaur, Iqbal R.
    Das, Shukla
    Bhattacharya, S. N.
    Singh, Anjani
    JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 58 (02) : 180 - 184
  • [9] THE T-HELPER CELL SHIFT IN AIDS - SIGNIFICANCE FOR PHARMACOTHERAPY
    CLERICI, M
    SHEARER, GM
    CLINICAL IMMUNOTHERAPEUTICS, 1995, 3 (02): : 95 - 101
  • [10] Ontogeny of T-helper 1 and T-helper 2 cytokine production in childhood
    Smart, JM
    Kemp, AS
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2001, 12 (04) : 181 - 187